<DOC>
	<DOC>NCT00363766</DOC>
	<brief_summary>The primary objective is to estimate the time to progressive disease for patients who receive LY573636 after two previous treatments for metastatic non-small cell lung cancer. Patients will receive an intravenous infusion of study drug once every 21 days. CT-scans will be done before the first dose and then after every other treatment.</brief_summary>
	<brief_title>Study of LY573636 in Patients With Metastatic Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<criteria>Diagnosis of metastatic nonsmallcell lung cancer At least 18 years of age Have received 2 previous treatment regimens for metastatic nonsmallcell lung cancer Serious preexisting medical conditions Previous cancer (except skin cancer, excluding melanoma) Have received 3 or more previous treatment regimens for metastatic non smallcell lung cancer Active treatment with Coumadin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>